Katherine A. Eade

Insider

First SEC filing: June 12, 2026 · Latest: June 12, 2026

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.

Insider at

HBIO buying Aug. 9, 2019

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 19 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

19 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 9, 2026	HBIO	A	16,556	—	—	58,669 Direct	+39.31%	Acquired	(price as of 2026-08-19)
July 16, 2025	HBIO	A	110,000	—	—	421,126 Direct	+35.36%	Acquired	(price as of 2026-08-19)
May 21, 2024	HBIO	A	45,872	—	—	311,126 Direct	+17.29%	Acquired	(price as of 2026-08-19)
May 22, 2023	HBIO	A	25,554	—	—	265,254 Direct	+10.66%	Acquired	(price as of 2026-08-19)
May 24, 2022	HBIO	A	38,259	—	—	239,700 Direct	+18.99%	Acquired	(price as of 2026-08-19)
Jan. 1, 2022	HBIO	A	2,525	—	—	201,441 Direct	+1.27%	Acquired	(price as of 2026-08-19)
Dec. 28, 2021	HBIO	A	1,401	—	—	198,916 Direct	+0.71%	Acquired	(price as of 2026-08-19)
May 25, 2021	HBIO	A	14,400	—	—	197,515 Direct	+7.86%	Acquired	(price as of 2026-08-19)
Jan. 4, 2021	HBIO	A	14,200	—	—	183,115 Direct	+8.41%	Acquired	(price as of 2026-08-19)
June 18, 2020	HBIO	A	28,100	—	—	168,915 Direct	+19.96%	Acquired	(price as of 2026-08-19)
Jan. 2, 2020	HBIO	A	19,300	—	—	140,815 Direct	+15.88%	Acquired	(price as of 2026-08-19)
Aug. 9, 2019	HBIO	P	39,915	$2.48	$98,989	121,515 Direct	+48.92%	Acquired	-71.6% (price as of 2026-08-19)
Aug. 1, 2019	HBIO	A	1,100	—	—	81,600 Direct	+1.37%	Acquired	(price as of 2026-08-19)
May 23, 2019	HBIO	A	35,100	—	—	80,500 Direct	+77.31%	Acquired	(price as of 2026-08-19)
Jan. 2, 2019	HBIO	A	12,700	—	—	45,400 Direct	+38.84%	Acquired	(price as of 2026-08-19)
June 1, 2018	HBIO	A	1,200	—	—	32,700 Direct	+3.81%	Acquired	(price as of 2026-08-19)
May 24, 2018	HBIO	A	18,100	—	—	31,500 Direct	+135.07%	Acquired	(price as of 2026-08-19)
Jan. 2, 2018	HBIO	A	11,100	—	—	13,400 Direct	+482.61%	Acquired	(price as of 2026-08-19)
Nov. 1, 2017	HBIO	A	2,300	—	—	2,300 Direct	—	Acquired	(price as of 2026-08-19)
Oct. 30, 2017	HBIO	A	87,600	—	—	87,600 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Oct. 30, 2017	HBIO	Non-Qualified Stock Option (right to buy)	Common Stock, par value $0.01 per share (87,600)	$3.33	Oct. 30, 2027	87,600	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).